Posted in | News | Energy

CAS Scientists Develop China's First RFQ Accelerator

Nov 23 2005

Related Stories

With the support of the National Program on Key Basic Research Projects (dubbed the 973 Program), researchers from the CAS Institute of High Energy Physics (IHEP) have developed the first Radio Frequency Quadrupole (RFQ) accelerator in China.

The RFQ accelerator is a major component of the 973 project "Basic Research for Physics and Technologies Related to an Accelerator Driven Clean Nuclear Energy System." By focusing on two selected schemes of the accelerator driven subcritical system (ADS), researcher are making efforts to address some of the problems facing the conventional nuclear power stations dominated by the pressurized water reactors (PWR). The success in RFQ development marks a big step forward for the ADS system studies in China, according to experts.

With the output energy up to3.5MeV and average current of 3mA, the RFQ accelerator, which is independently designed and fabricated by Chinese researchers at IHEP, is among the leading ones of such facilities in the world.

http://english.cas.ac.cn

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback